Docosahexaenoic Acid (DHA) Clinical Trials

• Study of Docosahexaenoic Acid (DHA) Supplementation in Patients with X-Linked Retinitis Pigmentosa
  ClinicalTrials.gov Identifier: NCT00004827 - Active, not recruiting
  Retinitis Pigmentosa
  
• DHA Supplement and Pregnancy Outcome
  ClinicalTrials.gov Identifier: NCT00266825 - Recruiting
  Pregnancy
  
• Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress
  ClinicalTrials.gov Identifier: NCT00014027 - Recruiting
  Healthy
  
• Effects of Docosahexaenoic Acid (DHA) on Cognitive Function in Children 4 Years of Age
  ClinicalTrials.gov Identifier: NCT00351624 - Recruiting
  Healthy
  
• DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00440050 - Active, not recruiting
  Alzheimer's Disease
  
• Effect of DHA Supplements on Macular Function in Patients with Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy
  ClinicalTrials.gov Identifier: NCT00060749 - Completed
  Macular Degeneration
  
• DHA and X-Linked Retinitis Pigmentosa
  ClinicalTrials.gov Identifier: NCT00100230 - Recruiting
  Retinitis Pigmentosa; X-linked Genetic Diseases
  
• Influence of DHA-Rich Supplement on DHA-Status and Health Evolution of Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00221546 - Active, not recruiting
  Cystic Fibrosis
  
• Memory Improvement With Docosahexaenoic Acid Study (MIDAS)
  ClinicalTrials.gov Identifier: NCT00278135 - Recruiting
  Age-Related Cognitive Decline; Age-Related Memory Disorders
  
• Docosahexaenoic Acid in the Treatment of Autism
  ClinicalTrials.gov Identifier: NCT00577447 - Completed
  Autistic Disorder
  
• DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00024414 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00024375 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00024401 - Active, not recruiting
  recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• DHA Supplementation in Patients With STGD3
  ClinicalTrials.gov Identifier: NCT00420602 - Active, not recruiting
  Dominantly Inherited Stargardt's Disease (STGD3)
  
• Activity of Essential Fatty Acid Elongation/Desaturation Pathway During Early Life in Human Infants, In Vivo
  ClinicalTrials.gov Identifier: NCT00342303 - Active, not recruiting
  Fatty Acid Metabolism
  
• A study to compare the efficacy of intravenous loading doses followed by maintenance treatment with oral ibandronic acid versus zoledronic acid in patients with skeletal metastases experiencing moderate to severe pain.
  ClinicalTrials.gov Identifier: NCT00099177 - Active, not recruiting
  Pain; Bone Neoplasms; Neoplasm Metastasis
  
• A study to compare the efficacy of intravenous loading doses followed by maintenance treatment with intravenous ibandronic acid versus zoledronic acid in patients with skeletal metastases experiencing moderate to severe pain.
  ClinicalTrials.gov Identifier: NCT00099203 - Active, not recruiting
  Pain; Bone Neoplasms; Neoplasm Metastasis
  
• Relationship Between Folic Acid and Warfarin Metabolism and Effect
  ClinicalTrials.gov Identifier: NCT00162409 - Recruiting
  Folic Acid Deficiency
  
• Double-Blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis)
  ClinicalTrials.gov Identifier: NCT00145327 - Active, not recruiting
  Osteoporosis
  
• Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults
  ClinicalTrials.gov Identifier: NCT00480207 - Recruiting
  Depression
  
• On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication
  ClinicalTrials.gov Identifier: NCT00161096 - Active, not recruiting
  Chronic Use of Acid Suppressive Medication; GORD; GERD; Reflux; Peptic Ulcer
  
• Evaluation of DHA for the Treatment of PSC
  ClinicalTrials.gov Identifier: NCT00325013 - Recruiting
  Primary Sclerosing Cholangitis; Colitis; PSC
  
• PET Imaging of DHA Metabolism
  ClinicalTrials.gov Identifier: NCT00074503 - Recruiting
  Healthy
  
• Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression
  ClinicalTrials.gov Identifier: NCT00361374 - Recruiting
  Major Depressive Disorder
  
• Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00045006 - Active, not recruiting
  Cancer
  
• Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)
  ClinicalTrials.gov Identifier: NCT00000621 - Active, not recruiting
  Emphysema; Lung Diseases; Lung Diseases, Obstructive; Chronic Obstructive Pulmonary Disease
  
• Efficacy and Safety of Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women with Osteopenia, 45 Years of Age and Older.
  ClinicalTrials.gov Identifier: NCT00132808 - Active, not recruiting
  Osteopenia (osteoporosis prevention)
  
• Randomized Phase Iii-Study On Valproic Acid In Combination With All-Trans Retinoic Acid, Standard Induction- And Consolidation Therapy In Older Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00151255 - Recruiting
  Acute myeloid leukemia, age > 60 years
  
• Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole
  ClinicalTrials.gov Identifier: NCT00542347 - Recruiting
  Gastric Acid
  
• The Effect of Folic Acid on Efficacy of Sulfadoxine-Pyrimethamine in Pregnant Women in Western Kenya
  ClinicalTrials.gov Identifier: NCT00130065 - Active, not recruiting
  Malaria
  
• Randomized Phase Ii-Study On Valproic Acid, All-Trans Retinoic Acid And Their Combination In Induction And Consolidation Therapy As Well As Pegfilgrastim After Consolidation Therapy In Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00151242 - Recruiting
  Acute Myeloid Leukemia
  
• A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00127127 - Active, not recruiting
  Tumors
  
• Controlled Trial of 4-Aminosalicylic Acid in Patients with Small Bowel Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00004423 - Active, not recruiting
  Crohn's Disease
  
• An Investigational Drug Study with Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00097929 - Active, not recruiting
  B-Cell Lymphoma
  
• Use of Formula Fortified With DHA in Infants With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00530244 - Recruiting
  Cystic Fibrosis
  
• Safety and Efficacy Trial with Zoledronic Acid for the Treatment of Paget's Disease of Bone
  ClinicalTrials.gov Identifier: NCT00103740 - Active, not recruiting
  Paget's Disease of Bone
  
• Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants
  ClinicalTrials.gov Identifier: NCT00004410 - Recruiting
  Cholestasis
  
• A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Malignant Lymphoma
  ClinicalTrials.gov Identifier: NCT00127140 - Active, not recruiting
  Malignant Lymphoma
  
• The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
  ClinicalTrials.gov Identifier: NCT00360217 - Recruiting
  Hypertriglyceridemia (TG>200<500); Hyperlipidemia; Coronary Artery Disease; Coronary Risk Equivalent; Diabetes
  
• Suberoylanilide Hydroxamic Acid in Treating Patients With Relapsed Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00124631 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma
  
• High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed
  ClinicalTrials.gov Identifier: NCT00002650 - Active, not recruiting
  Rectal Cancer; prevention of colorectal cancer; Colon Cancer
  
• Omega-3 Fatty Acid Status in Morbid Obesity Before and After Surgical Treatment
  ClinicalTrials.gov Identifier: NCT00558532 - Recruiting
  Morbid Obesity; Cardiovascular Disease; Fatty Acid Levels
  
• Suberoylanilide Hydroxamic Acid and Capecitabine in Treating Patients with Metastatic Or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00121277 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Valproic Acid in Treating Patients With Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00075777 - Active, not recruiting
  recurrent Kaposi's sarcoma; epidemic Kaposi's sarcoma
  
• Lactic Acid in the Rectum and Life-Threatening Infection.
  ClinicalTrials.gov Identifier: NCT00197938 - Recruiting
  Septic Shock
  
• Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00005634 - Active, not recruiting
  Leukemia; Lymphoma; Prostate Cancer; Multiple Myeloma; Eye Cancer
  
• Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003697 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Pilot Study to Evaluate Nucleic Acid Amplification Methods in the Diagnosis and Management of Active TB
  ClinicalTrials.gov Identifier: NCT00023439 - Recruiting
  Tuberculosis
  
• Study of Treatment and Metabolism in Patients With Urea Cycle Disorders
  ClinicalTrials.gov Identifier: NCT00004307 - Recruiting
  Amino Acid Metabolism, Inborn Errors
  
• Study of Zoledronic Acid for Patients With Hormone-Sensitive Bone Metastases From Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00242567 - Recruiting
  Prostate Cancer
  
• Suberoylanilide Hydroxamic Acid in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00132067 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00263484 - Recruiting
  Multiple Myeloma
  
• Painful HIV Neuropathy and Alpha-Lipoic Acid
  ClinicalTrials.gov Identifier: NCT00079807 - Active, not recruiting
  HIV; Peripheral Neuropathy
  
• Ursodesoxycholic Acid in the Treatment of Duodenal Adenomas in FAP Patients.
  ClinicalTrials.gov Identifier: NCT00134758 - Recruiting
  Adenomatous Polyposis Coli; Adenoma
  
• Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year
  ClinicalTrials.gov Identifier: NCT00424983 - Recruiting
  Multiple Myeloma; Breast Cancer
  
• Clinical and Laboratory Study of Methylmalonic Acidemia
  ClinicalTrials.gov Identifier: NCT00078078 - Recruiting
  Amino Acid Metabolism; Inborn Errors
  
• Functional and Molecular Characterisation of Oesophageal Distal Epithelium: Correlations With Acid and Non Acid Reflux
  ClinicalTrials.gov Identifier: NCT00231881 - Recruiting
  Gastro-Oesophageal Reflux
  
• Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)
  ClinicalTrials.gov Identifier: NCT00410566 - Recruiting
  Acid Sphingomyelinase Deficiency; Niemann-Pick Disease
  
• Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00024310 - Active, not recruiting
  Drug Toxicity; unspecified adult solid tumor, protocol specific
  
• Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00132002 - Active, not recruiting
  Male Breast Cancer; stage IV breast cancer; recurrent breast cancer
  
• The Effect of Fatty Acid Composition on Energy Intake and Satiety
  ClinicalTrials.gov Identifier: NCT00242021 - Active, not recruiting
  Obesity
  
• Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
  ClinicalTrials.gov Identifier: NCT00295646 - Active, not recruiting
  Breast Cancer
  
• Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00134043 - Active, not recruiting
  follicular thyroid cancer; insular thyroid cancer; medullary thyroid cancer; papillary thyroid cancer; Thyroid Cancer
  
• Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps
  ClinicalTrials.gov Identifier: NCT00033319 - Active, not recruiting
  prevention of colorectal cancer; Colon Cancer; Rectal Cancer
  
• Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
  ClinicalTrials.gov Identifier: NCT00107458 - Active, not recruiting
  childhood brain tumor; childhood meningioma; childhood solid tumor; childhood spinal cord tumors
  
• 24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00555789 - Recruiting
  Kidney Transplantation
  
• Nicotinic Acid - Pharmacokinetics, Pharmacodynamics, Receptor Expression
  ClinicalTrials.gov Identifier: NCT00176020 - Not yet recruiting
  Nicotinic Acid; Flush Symptom; Pharmacodynamic; Pharmacokinetic
  
• D4T or Abacavir Plus Vitamin Enhancement (DAVE)
  ClinicalTrials.gov Identifier: NCT00143702 - Recruiting
  Elevated Lactic Acid
  
• Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal
  ClinicalTrials.gov Identifier: NCT00256633 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Efficacy of Weekly Versus Daily Folic Acid Supplementation
  ClinicalTrials.gov Identifier: NCT00394862 - Active, not recruiting
  Neural Tube Defects
  
• Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
  ClinicalTrials.gov Identifier: NCT00149409 - Recruiting
  Chronic Heart Failure
  
• Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression
  ClinicalTrials.gov Identifier: NCT00444236 - Not yet recruiting
  Exercise Triggered Asthma; Gastroesophageal Reflux
  
• Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients
  ClinicalTrials.gov Identifier: NCT00222131 - Active, not recruiting
  Indigestion
  
• Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00004441 - Recruiting
  Cystic Fibrosis
  
• Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy and Pharmacokinetics of Myozyme in Patients with Late-Onset Pompe Disease.
  ClinicalTrials.gov Identifier: NCT00158600 - Active, not recruiting
  Pompe Disease (Late-onset); Glycogen storage disease type II (GSD-II); Acid Maltase Deficiency Disease; Glycogenosis 2
  
• Suberoylanilide Hydroxamic Acid in Treating Patients With Relapsed or Refractory Advanced Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00132028 - Active, not recruiting
  recurrent adult Hodgkin''s lymphoma; stage IV adult Hodgkin''s lymphoma; adult lymphocyte depletion Hodgkin''s lymphoma; ...
  
• Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00403416 - Active, not recruiting
  Kidney Transplantation
  
• PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS
  ClinicalTrials.gov Identifier: NCT00439673 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule
  ClinicalTrials.gov Identifier: NCT00579410 - Active, not recruiting
  Esophagitis; Inflammation; Gastritis; Abdominal Pain; Heartburn
  
• Chemotherapy in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00024388 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery
  ClinicalTrials.gov Identifier: NCT00320619 - Active, not recruiting
  Scoliosis; Kyphosis; Lordosis; Spondylitis; Spinal Stenosis
  
• Evaluation of Efficacy and Safety of Omacor (Omega-3-Acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate)
  ClinicalTrials.gov Identifier: NCT00246636 - Active, not recruiting
  Hypertriglyceridemia
  
• Study on Amino Acid Uptake in Brain Tumors
  ClinicalTrials.gov Identifier: NCT00204295 - Active, not recruiting
  Brain Neoplasms
  
• Effects of Fatty Acid Supplementation on Substance Dependent Individuals
  ClinicalTrials.gov Identifier: NCT00312455 - Active, not recruiting
  Substance-Related Disorders
  
• A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00373490 - Active, not recruiting
  Tumors
  
• ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00533169 - Active, not recruiting
  Neuroblastoma
  
• Long-Term Analysis of Urea Cycle Disorders
  ClinicalTrials.gov Identifier: NCT00237315 - Recruiting
  Brain Diseases, Metabolic, Inborn; Amino Acid Metabolism, Inborn Errors
  
• Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response
  ClinicalTrials.gov Identifier: NCT00392002 - Active, not recruiting
  Gastroesophageal Reflux
  
• Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Post Menopausal Women With Osteoporosis
  ClinicalTrials.gov Identifier: NCT00404820 - Active, not recruiting
  Osteoporosis
  
• Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00084981 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention
  ClinicalTrials.gov Identifier: NCT00164008 - Active, not recruiting
  Osteopenia; Heart Transplantation; Lung Transplantation
  
• Azacytidine With Valproic Acid Versus Ara-C in AML/MDS Patients
  ClinicalTrials.gov Identifier: NCT00382590 - Active, not recruiting
  Acute Myelogenous Leukemia; Myelodysplastic Syndrome; Leukemia
  
• Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis
  ClinicalTrials.gov Identifier: NCT00004346 - Recruiting
  Cerebrotendinous Xanthomatosis
  
• Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00106626 - Recruiting
  Neoplasms; Mesothelioma; Non-Small-Cell Lung Carcinoma
  
• Ascorbic Acid Treatment in CMT1A Trial (AATIC)
  ClinicalTrials.gov Identifier: NCT00271635 - Recruiting
  Charcot-Marie-Tooth Disease; Hereditary Motor and Sensory Neuropathies
  
• Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients with End Stage Renal Disease Receiving Hemodialysis
  ClinicalTrials.gov Identifier: NCT00004495 - Recruiting
  End Stage Renal Disease; Hyperhomocysteinemia
  
• Long-Term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)
  ClinicalTrials.gov Identifier: NCT00261300 - Active, not recruiting
  GERD; Gastroesophageal Reflux Disease; Peptic Ulcers
  
• Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-Term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids
  ClinicalTrials.gov Identifier: NCT00284947 - Active, not recruiting
  Kidney Transplantation; Adverse Effects
  
• Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication
  ClinicalTrials.gov Identifier: NCT00202280 - Active, not recruiting
  First Episode Psychosis
  
• Effect of Long Term α-Lipoic Acid Treatment on Endothelial Function in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00490867 - Active, not recruiting
  Type 2 Diabetes